Ganglioside GM2 on the K562 cell line is recognized as a target structure by human natural killer cells

International Journal of Cancer

Volumn 40, Issue 1, 1987, Pages 12-17

  Ando, Iwao ^a   Hoon, Dave S B ^a   Suzuki, Yasuo ^a   Saxton, Romaine E ^b   Golub, Sidney H ^a   Irie, Reiko F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE;

BLOOD AND HEMOPOIETIC SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; TARGET CELL; THERAPY;

BINDING SITES; CELL LINE; G(M2) GANGLIOSIDE; GANGLIOSIDES; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA; MULTIPLE MYELOMA;

EID: 0023188777     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910400104     Document Type: Article

References (28)

1. Specific effect of anti‐Transferrin antibodies on natural killer cells directed against tumor cells. Evidence for the transferrin receptor being one of the target structures recognized by NK cells
2. Characteristics of human NK clones: target specificity and phenotype
3. Role of natural killer cytotoxic factors in the mechanism of target‐Cell killing by natural killer cells
4. Ganglioside mediated modulation of cell growth, growth factor binding and receptor phosphorylation
5. Identification of a human neuroectodermal tumor antigen (oFA‐1–2) as ganglioside GD2
6. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives
7. Natural killer cells: characteristics and regulation of activity
8. Phenotypic and functional heterogeneity of human cloned natural killer cell lines
9. Human antibody to OFA‐I, a tumor antigen, produced in vitro by EBV‐Transformed human B‐Lympho‐Blastoic cell lines
10. The sialic acids. XI. A periodateresorcinol method for the quantitative estimation of free sialic acids and their glycosides
11. Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells
12. NK cell lineage and target specificity: a unifying concept
13. Human monoclonal antibody to tumor associated ganglioside GD2
14. Gangliosides of human myelin: sialosylgalactosylceramide (g7) as a major component
15. Proteoglycans in cell‐Mediated cytotoxicity
16. Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes
17. High resolution preparative column chromatographic system for gangliosides using DEAE‐Sephadex and new porous silica, Iatrobeads
18. Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity
19. The role of transferrin in natural killer cells and IL‐2 induced cytotoxic cell function
20. Glycosphingolipids of K562 cells: a chemical and immunological analysis
21. Immunogenicity of melanoma‐Associated gangliosides in cancer patients
22. Ganglioside GM2 as a human tumor antigen (oFA‐I‐1)
23. Human natural killer cells: biologic and pathologic aspects
24. Recycling and target binding capacity of human natural killer cells
25. Receptor for transferrin may be a “target” structure for natural killer cells
26. Studies on natural, antibody‐Dependent, and interleukin‐2‐Activated killer cell activity of a patient with mucolipidosis III as a test of mannose‐6‐Phosphate lytic acceptor hypothesis
27. Studies on the mechanism of natural killer cell‐Mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine or rat effector cells stimulated with mycoplasma‐Free cell lines